文献速递中医内科中药与中成药合理使用

治龙活血通瘀胶囊治疗心脑血管疾病的系统综述:药理作用、分子机制与临床结局

A systematic review on Zhilong Huoxue Tongyu capsule in treating cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms and clinical outcomes.
PubMed 文献 · J Ethnopharmacol · 2021-05-24

该综述综合网络药理学、分子对接、动物实验及2000至2020年文献,总结治龙活血通瘀胶囊的主要成分、作用机制与临床方案。结果显示其通过多成分多靶点多通路发挥抗炎、抗凋亡和促血管生成作用,逾1000例临床病例获益,体现「异病同治」整体观。

要点

  • 治龙活血通瘀胶囊通过多成分多靶点多通路发挥抗炎、抗凋亡及促血管生成作用。
  • 逾1000例临床病例显示该胶囊对心脑血管疾病有满意疗效,体现异病同治。
  • 该综述为中药复方治疗心脑血管疾病的物质基础与药效学研究提供参考。

核心结论

  • 治龙活血通瘀胶囊通过多成分作用于多靶点、多通路,发挥抗炎、抗凋亡和促血管生成作用,治疗心脑血管疾病。
  • 超过1000例临床病例从该胶囊治疗中获益,提示「异病同治」的整体观念。

研究设计与样本

  • 系统综述,采用网络药理学分析主要活性化合物并预测抗动脉粥样硬化机制,分子对接模拟活性成分与靶点相互作用。
  • 检索PubMed、Web of Science、中国知网和Google Scholar,关键词包括「Zhilong Huoxue Tongyu capsule」「cardiovascular and cerebrovascular diseases」「atherosclerosis」「clinical study」及其组合,主要检索2000至2020年文献。

主要发现

  • 网络药理学分析、分子对接和动物实验研究均证实,该胶囊通过多成分作用于多靶点、多通路,发挥抗炎、抗凋亡和促血管生成作用。
  • 超过1000例临床病例从该胶囊治疗中获益,提示「异病同治」的整体观念。

关键数值与推荐

  • 网络药理学分析、分子对接和动物实验研究均证实其抗炎、抗凋亡和促血管生成机制。
  • 超过1000例临床病例从治疗中获益。

临床怎么用

  • 该胶囊基于黄芪、水蛭、地龙、肉桂和红藤组成,具有补气活血、祛风化痰功效,可用于心脑血管疾病。
  • 临床可依据「异病同治」整体观念,将治龙活血通瘀胶囊用于心肌与脑部不同疾病的治疗。

局限性

  • 文献检索主要限定于2000至2020年,可能未涵盖此后研究。
  • 原文未报告所纳入临床研究的具体设计、样本量、对照设置及偏倚风险等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Cardiovascular and cerebrovascular diseases have become a severe threat for human health worldwide, however, optimal therapeutic options are still developed. Zhilong Huoxue Tongyu capsule (ZL capsule) is mainly composed of Astragalus membranaceus, Leech, Earthworm, Cinnamomum cassia and Sargentodoxa cuneata, having functions of replenishing qi and activating blood, dispelling wind and reducing phlegm. It is an expanded application on the basis of traditional uses of above TCMs, acquiring a satisfactory curative effect on cardiovascular and cerebrovascular diseases over twenty years. AIM OF THE STUDY: To comprehensively summarize the main components of ZL capsule, understand the mechanisms of ZL capsule, and conclude clinical regimens of ZL capsule for cardiovascular and cerebrovascular diseases. MATERIALS AND METHODS: We selected network pharmacology technology to analyze main active compounds and predict underlying mechanism of ZL capsule against atherosclerosis. Molecular docking was performed to simulate the interaction pattern between the active components of ZL capsule and putative targets. Further, PubMed, Web of Science, China National Knowledge Infrastructure and Google Scholar were used to search literatures, with the key words of "Zhilong Huoxue Tongyu capsule", "cardiovascular and cerebrovascular diseases", "atherosclerosis", "clinical study" and their combinations, mainly from 2000 to 2020. RESULTS: Both network pharmacology analysis, molecular docking and animal experiments studies confirmed that mechanisms of ZL capsule plays the role of anti-inflammatory, anti-apoptosis and promoting angiogenesis in treating cardiovascular and cerebrovascular diseases by multi-components acting on multi-targets via multi-pathways. Over 1000 clinical cases were benefited from the treatment of ZL capsule, suggesting a holistic concept of "the same therapy for different myocardial and cerebral diseases". CONCLUSIONS: For the first time, this systematic review may supply meaningful information for further studies to explore material basis and pharmacodynamics of ZL capsule and also provide a basis for sharing the "Chinese patent medicine" for cardiovascular and cerebrovascular diseases.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Liang P, Mao L, Ma Y, et al. A systematic review on Zhilong Huoxue Tongyu capsule in treating cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms and clinical outcomes. J Ethnopharmacol. 2021. PMID: 34044079. doi:10.1016/j.jep.2021.114234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。